Short-term insulin therapy in adolescents with type 2 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 11, 2004, Pages 1561-1564

  Sellers, Elizabeth A C ^a   Dean, H J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adolescents; Insulin; Pediatrics; Therapy; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENCE; ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHILD CARE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PATIENT MONITORING; PILOT STUDY; SCHOOL CHILD; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 8644252831     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.11.1561     Document Type: Article

References (11)

1. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, Narayan KM. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000; 136: 664-672.
2. Dean H, Flett B. Natural history of type 2 diabetes diagnosed in childhood: long term follow-up in young adult years. Diabetes 2002; 51 (Suppl 2): A24.
3. Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002; 25: 89-94.
4. Yki-Jarvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415-431.
5. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281-303.
6. Dean H. Diagnostic criteria for non-insulin dependent diabetes in youth (NIDDM-Y). Clin Pediatr (Phila) 1998; 37: 67-79.
7. UKPDS Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
8. Dean H. NIDDM-Y in First Nation children in Canada. Clin Pediatr (Phila) 1998; 37: 89-96.
9. Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 1997; 20: 1353-1356.
10. Andrews WJ, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven GM. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 1984; 33: 634-642.
11. Ryan EA, Imes S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 2004; 27: 1028-1032.